Artificial intelligence is increasingly becoming a cornerstone in pharmaceutical research, with numerous companies leveraging ...

Isomorphic Labs is the secretive AI life sciences startup spun out of Google DeepMind with the goal of solving all disease ...

Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital ...

The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...

Google gave an update on various aspects of its health-related R&D at its annual event The Check Up, including a new collection of artificial intelligence (AI) models intended to support drug ...

AlphaFold is an artificial intelligence system that revolutionized our understanding of protein structures advancing research and drug discovery. The project was led by Google DeepMind CEO Demis ...

During a health-focused event in New York on Tuesday, Google announced that it’s developing a collection of “open” AI models for drug discovery called TxGemma. The AI models, which Google ...

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

Google-Backed AI Drug Discovery Startup Raises $600 Million (Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...